AVNS Q4 2024 Earnings — Avanos Medical, Inc. Revenue & Financial Results | Market Cap Arena

AVNSAvanos Medical, Inc.

$621M

Q4 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$180M+3.6% YoY

Gross Profit

$99M55.3% margin

Operating Income

$13M7.0% margin

Net Income

-$397M-221.2% margin

EPS (Diluted)

$-8.64

QoQ Revenue Growth

+5.4%

Cash Flow

Operating Cash Flow

$58M

Free Cash Flow

$53M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$326M

Stockholders' Equity

$829M

Cash & Equivalents

$108M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$180M	$173M	+3.6%
Gross Profit	$99M	$95M	+4.5%
Operating Income	$13M	$22M	-43.7%
Net Income	-$397M	$11M	-3883.8%

Revenue Segments

Digestive Health

$106M100%